We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
-28.7%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
10 Year Est. Return
AUM
$21M
AUM Growth
-$13.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIGL
1
DELISTED
Vigil Neuroscience
VIGL
$14.2M 67.78%
4,214,498
TBIO
2
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$3.93M 18.69%
546,896
CADL icon
3
Candel Therapeutics
CADL
$723M
$2.84M 13.54%
1,935,215

Similar funds

Northpond Ventures's Q4 2023 Portfolio in Review

As of Q4 2023, Northpond Ventures held 3 positions worth $21M, down 39% from $34.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 0%. Northpond Ventures opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures's ten largest holdings make up 100% of its $21M portfolio in Q4 2023.
  • Northpond Ventures opened 0 new positions and closed 0 in Q4 2023.
  • Northpond Ventures's portfolio value fell 39% quarter-over-quarter to $21M.

Based on Northpond Ventures's 13F filing for Q4 2023, filed 14 Feb 2024.